Literature DB >> 20204236

[Epidemiology of retinopathy of prematurity in public services from Argentina during 2008].

Celia C Lomuto1, Lidia Galina, Marina Brussa, Ana Quiroga, Ernesto Alda, Alicia M Benítez, Liliana Bouzas, N Alejandro Dinerstein, Norma Erpen, Jorgelina Falbo, Julio Manzitti, Silvia Marinaro, Ricardo Nieto, Teresa Sepúlveda, Patricia Visintín.   

Abstract

INTRODUCTION: Increasing survival of preterm newborns and current care deficits result in high rates of retinopathy of prematurity (ROP), affecting patients with higher birth weight (BW) and gestational age (GA) than those at developed countries; unusual cases (UC) and missed opportunities (MO) are reported.
OBJECTIVE: To describe epidemiology of ROP during 2008 compared with the previous year. POPULATION, MATERIAL AND
METHOD: Observational, descriptive and retrospective study. POPULATION: Preterm babies with BW < 1,500 g and/or < or = 32 w GA and > or = 1,500 g and/or 33-36 w who received oxygen therapy. SOURCE: 31 public services from 20/24 Provinces. VARIABLES: BW, GA, ophthalmologic screening, age at 1st control, ROP Grade, treatment requirement, place of treatment and time of complete ROP screening.
RESULTS: Responses were obtained from 24/31 services from 16 Provinces (84,200 newborns) identifying 3,371 newborns at risk, 956 < 1,500 g BW. Screening was done in 90%; it was late in 6%. Neonatal discharge before complete ROP screening occurred in 93%. ROP rate was 11.93%; 26.25% in < 1,500 g BW. Treatment was required at 2.60%; of them, 7% were < 1,500 g BW; 20.3% were UC, one infant was a MO. Treatment need increased 20% at 2008 vs. 2007, without significant difference. Changes were not observed at median BW and GA and UC. Treatment in situ was 75% in 2008, similar to 2007.
CONCLUSIONS: Incidence of ROP in public hospitals of Argentina is worrisome. Rates in 2008 have not improved compared with 2007, expressing that criteria for prevention are not yet consolidated. Screening and access to treatment must improve.

Entities:  

Mesh:

Year:  2010        PMID: 20204236     DOI: 10.1590/S0325-00752010000100006

Source DB:  PubMed          Journal:  Arch Argent Pediatr        ISSN: 0325-0075            Impact factor:   0.635


  3 in total

1.  Effects of aminoguanidine on retinal apoptosis in mice with oxygen-induced retinopathy.

Authors:  An-Jie Du; Bing Ren; Xiao-Wei Gao; Lei Yang; Yan Fu; Xu-Dong Zhao
Journal:  Int J Ophthalmol       Date:  2013-08-18       Impact factor: 1.779

2.  Prevalence of retinopathy of prematurity in Latin America.

Authors:  Juliana Zimmermann Carrion; João Borges Fortes Filho; Marcia Beatriz Tartarella; Andrea Zin; Ignozy Dorneles Jornada
Journal:  Clin Ophthalmol       Date:  2011-12-01

3.  Incidence and risk factors for retinopathy of prematurity: a retrospective cohort study.

Authors:  André Moraes Freitas; Ricardo Mörschbächer; Mariana R Thorell; Ernani Luis Rhoden
Journal:  Int J Retina Vitreous       Date:  2018-05-31
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.